Clinical Trial Update: Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating S-1 capsule as adjuvant therapy after complete resection for stage II to IIIA non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Non-small Cell Lung Cancer Stage Ⅱ, Non-small Cell Lung Cancer Stage ⅢA | Phase 2 | Status: UNKNOWN